Investing.com - Cano Health (NYSE: CANO) reported first quarter EPS of $-0.12, $0.01 better than the analyst estimate of $-0.13. Revenue for the quarter came in at $866.9M versus the consensus estimate of $810.98M.
Guidance
Cano Health sees FY 2023 revenue of $3.25B-$3.35B versus the analyst consensus of $3.16B.
Cano Health's stock price closed at $1.03. It is down -35.22% in the last 3 months and down -75.12% in the last 12 months.
Cano Health saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Cano Health's stock price’s past reactions to earnings here.
According to InvestingPro, Cano Health's Financial Health score is "fair performance".
Check out Cano Health's recent earnings performance, and Cano Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar